ATE458724T1 - N-heterocyclische inhibitoren der expression von tnf-alpha - Google Patents

N-heterocyclische inhibitoren der expression von tnf-alpha

Info

Publication number
ATE458724T1
ATE458724T1 AT02739978T AT02739978T ATE458724T1 AT E458724 T1 ATE458724 T1 AT E458724T1 AT 02739978 T AT02739978 T AT 02739978T AT 02739978 T AT02739978 T AT 02739978T AT E458724 T1 ATE458724 T1 AT E458724T1
Authority
AT
Austria
Prior art keywords
tnf
alpha expression
compounds
heterocyclic inhibitors
disclosed
Prior art date
Application number
AT02739978T
Other languages
English (en)
Inventor
Kevin Moriarty
Yvonne Shimshock
Gulzar Ahmed
Junjun Wu
James Wen
Wei Li
Shawn ERICKSON
Jeffrey Letourneau
Edward Mcdonald
Katerina Leftheris
Stephen Wrobleski
Zahid Hussain
Ian Henderson
Axel Metzger
John Baldwin
Alaric Dyckman
Original Assignee
Bristol Myers Squibb Co
Pharmacopeia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/891,750 external-priority patent/US6906067B2/en
Application filed by Bristol Myers Squibb Co, Pharmacopeia Inc filed Critical Bristol Myers Squibb Co
Priority claimed from PCT/US2002/020212 external-priority patent/WO2003002542A1/en
Application granted granted Critical
Publication of ATE458724T1 publication Critical patent/ATE458724T1/de

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02739978T 2001-06-26 2002-06-25 N-heterocyclische inhibitoren der expression von tnf-alpha ATE458724T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/891,750 US6906067B2 (en) 1999-12-28 2001-06-26 N-heterocyclic inhibitors of TNF-α expression
PCT/US2002/020212 WO2003002542A1 (en) 2000-12-22 2002-06-25 N-heterocyclic inhibitors of tnf-alpha expression

Publications (1)

Publication Number Publication Date
ATE458724T1 true ATE458724T1 (de) 2010-03-15

Family

ID=31947149

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02739978T ATE458724T1 (de) 2001-06-26 2002-06-25 N-heterocyclische inhibitoren der expression von tnf-alpha

Country Status (7)

Country Link
EP (1) EP1409463B1 (de)
JP (1) JP2004535446A (de)
AT (1) ATE458724T1 (de)
CA (1) CA2451125A1 (de)
DE (1) DE60235470D1 (de)
ES (1) ES2339226T3 (de)
HU (1) HUP0401712A3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1909910A1 (de) * 2005-08-04 2008-04-16 Sirtris Pharmaceuticals, Inc. Benzimidazol-derivative als sirtuin-modulatoren
EP1957443A2 (de) * 2005-12-01 2008-08-20 Basf Se Verfahren zur herstellung von sulfonamiden
WO2008016675A1 (en) * 2006-08-01 2008-02-07 Praecis Pharmaceuticals Incorporated P38 kinase inhibitors
BRPI0818408B1 (pt) 2007-10-12 2024-01-09 Basf Se Processos para preparar diamidas sulfúricas e ingredientes herbicidas ativos
EP2331506B1 (de) * 2008-09-02 2013-07-03 Boehringer Ingelheim International GmbH Neue benzamide, deren herstellung und deren verwendung als arzneimittel
EP2646423A4 (de) * 2010-11-29 2014-04-30 Galleon Pharmaceuticals Inc Neue verbindungen als atemstimulantien zur behandlung von atmungsteuerungsstörungen oder erkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311614B1 (no) * 1996-10-01 2001-12-17 Janssen Pharmaceutica Nv Substituerte diamino-1,3,5-triazinderivater
WO1999001442A1 (en) * 1997-07-02 1999-01-14 Zeneca Limited Triazine derivatives and their use as antibacterial agents
ATE449764T1 (de) * 1999-12-28 2009-12-15 Pharmacopeia Inc Cytokine, insbesondere tnf-alpha, hemmer

Also Published As

Publication number Publication date
EP1409463B1 (de) 2010-02-24
EP1409463A1 (de) 2004-04-21
CA2451125A1 (en) 2003-01-09
EP1409463A4 (de) 2004-11-17
DE60235470D1 (de) 2010-04-08
HUP0401712A3 (en) 2009-06-29
HUP0401712A2 (hu) 2004-12-28
ES2339226T3 (es) 2010-05-18
JP2004535446A (ja) 2004-11-25

Similar Documents

Publication Publication Date Title
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
SE0101675D0 (sv) Novel composition
ATE556713T1 (de) Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
PL406680A1 (pl) Inhibitory kinaz tyrozynowych
ATE529109T1 (de) Hemmung der p38 kinase aktivität durch substituierte heterocyclische harnstoffe
ATE346600T1 (de) Inhibierung der p38 kinase-aktivität durch die verwendung von aryl- und heteroarylsubstituierten harnstoffen
YU49101A (sh) Karboksiaril supstituisani difenil karbamidi kao inhibitori raf kinaze
ATE316785T1 (de) Jak-3 hemmer zur behandlung von allergischen störungen
ATE517896T1 (de) P38-kinase-inhibitoren
ATE339418T1 (de) Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
DE60316013D1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
ATE478664T1 (de) Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren
NO20070526L (no) Kinazolindionderivater som parp-inhibitorer
NO20053470L (no) Triazolopyridaziner som proteinkinase-inhibitorer
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE602004018780D1 (de) Inhibitoren von thienopyridin- und furopyridinkinase
ATE413388T1 (de) Muskarin antagonisten
ATE554087T1 (de) Neue kinaseinhibitoren
WO2004030620A3 (en) Novel tyrosine kinase inhibitors
ATE288747T1 (de) Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren
ATE403433T1 (de) Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen
ATE501128T1 (de) 1,2,3-triazolamidderivate als inhibitoren der cytokinproduktion
BRPI0512547A (pt) pirimidinas
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
DE60329326D1 (de) Tace inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties